STOCK TITAN
  1. Home
  2. Sec-filings
  3. VTRS
  4. [8-K] Viatris Inc Reports Material Event

Viatris (NASDAQ: VTRS) taps Matthew Maletta as new Chief Legal Officer

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Viatris Inc. reported a leadership change in its top legal role. Chief Legal Officer Brian Roman will step down from that position effective February 9, 2026 and remain with the company until April 1, 2026 to support the transition.

In connection with his departure, he will be eligible for separation payments equal to his base salary plus target bonus and a pro rata 2026 bonus, consistent with benefits for similar executives, and would sign a customary release of claims. Viatris also announced that Matthew Maletta, who previously served as Executive Vice President, Chief Legal Officer and Secretary of Endo, Inc. from 2015 to 2025, will join as Chief Legal Officer on February 9, 2026.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Understanding 8-K Material Events →
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 29, 2026


VIATRIS INC.
(Exact name of registrant as specified in its charter)


Delaware
001-39695
 83-4364296
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)

1000 Mylan Boulevard, Canonsburg, Pennsylvania, 15317
(Address of Principal Executive Offices)

Registrant’s telephone number, including area code: (724) 514-1800


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

  ☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

  ☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  ☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

  ☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
  
Trading
Symbol(s)
  
Name of each exchange
on which registered
Common Stock, par value $0.01 per share
  
VTRS
   The NASDAQ Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 5.02         Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 3, 2026, Viatris Inc. (the “Company”) announced that Brian Roman, Chief Legal Officer of the Company, would transition from his role with the Company and cease to serve as Chief Legal Officer effective as of February 9, 2026.  Mr. Roman will remain an employee of the Company until April 1, 2026 for transitional purposes.  In connection with his departure from the Company, Mr. Roman will be eligible to receive separation payments equal to the sum of his base salary plus target bonus and a pro rata bonus for 2026, consistent with severance benefits paid to similarly situated executives.  Mr. Roman would also execute a customary release of claims.

On February 3, 2026, the Company also announced that Matthew Maletta will join the Company as Chief Legal Officer on February 9, 2026.  Mr. Maletta is a seasoned legal professional in the pharmaceutical industry, having served from 2015 to 2025 as Executive Vice President, Chief Legal Officer and Secretary of Endo, Inc.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
VIATRIS INC.



Date: February 3, 2026
 By: /s/ Theodora Mistras


Theodora Mistras


Chief Financial Officer


Source: View Original Filing on SEC EDGAR

FAQ

What executive change did Viatris (VTRS) disclose in this 8-K?

Viatris disclosed that Chief Legal Officer Brian Roman will leave his role effective February 9, 2026, remaining as an employee until April 1, 2026 for transition. The company simultaneously appointed experienced pharmaceutical attorney Matthew Maletta as its new Chief Legal Officer effective February 9, 2026.

What severance benefits will Brian Roman receive from Viatris (VTRS)?

Brian Roman will be eligible for separation payments equal to his base salary plus target bonus and a pro rata 2026 bonus. Viatris states these benefits are consistent with severance paid to similarly situated executives and are conditioned on his execution of a customary release of claims.

Does this Viatris leadership change affect other executive roles?

The disclosure focuses specifically on the Chief Legal Officer transition from Brian Roman to Matthew Maletta. No changes to other executive positions are described, and the filing is signed on behalf of Viatris by Chief Financial Officer Theodora Mistras under the Securities Exchange Act requirements.